What’s next in Neuroscience drug discovery

What’s next in Neuroscience drug discovery
hajdola1

/by
Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery
arcticnovartis

  • New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing global research sites including Cambridge, Massachusetts, and Basel, Switzerland
  • Approximately 466,000-square-foot site with AI-enabled discovery capabilities, expected to house about 1,000 employees
  • Part of a USD 23 billion US investment to expand R&D and advanced manufacturing to reach more patients

Basel, February 6, 2026 – Novartis today broke grou

/by
Novartis erzielte im Jahr 2025 eine Umsatzsteigerung im hohen einstelligen Prozentbereich, eine Kerngewinnmarge von 40% sowie weitere Fortschritte in der Pipeline

Novartis erzielte im Jahr 2025 eine Umsatzsteigerung im hohen einstelligen Prozentbereich, eine Kerngewinnmarge von 40% sowie weitere Fortschritte in der Pipeline
arcticnovartis

Ad-hoc-Mitteilung gemäss Art. 53 KR

Geschäftsjahr

/by
Novartis delivered high single-digit sales growth, achieved 40% core margin and further advanced the pipeline in 2025

Novartis delivered high single-digit sales growth, achieved 40% core margin and further advanced the pipeline in 2025
arcticnovartis

Ad hoc announcement pursuant to Art. 53 LR

Full year

/by
How Novartis is helping to eliminate leprosy

How Novartis is helping to eliminate leprosy
imberje1

/by